These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 20664597

  • 1. Non-responders to topical imiquimod followed by vaccination therapy in VIN patients may be due to the level of IL10.
    Liu XS.
    Br J Cancer; 2010 Aug 10; 103(4):595-6. PubMed ID: 20664597
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of vulvar intraepithelial neoplasia using topical imiquimod 5% cream in a genitourinary medicine clinic setting.
    McQuillan O, Morgan E.
    Int J STD AIDS; 2007 Jan 10; 18(1):63-4. PubMed ID: 17326867
    [Abstract] [Full Text] [Related]

  • 3. Letter to the Editor concerning "Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomized, double blinded study." Gynecologic Oncology 107 (2007) 219-222.
    van de Nieuwenhof HP, van der Avoort IA, Massuger LF, de Hullu JA.
    Gynecol Oncol; 2008 Jun 10; 109(3):430-1; author reply 431. PubMed ID: 18295871
    [No Abstract] [Full Text] [Related]

  • 4. Imiquimod in the treatment of multifocal vulvar intraepithelial neoplasia 2/3. Results of a pilot study.
    van Seters M, Fons G, van Beurden M.
    J Reprod Med; 2002 Sep 10; 47(9):701-5. PubMed ID: 12380448
    [Abstract] [Full Text] [Related]

  • 5. Adjuvant topical treatment with imiquimod 5% after excisional surgery for VIN 2/3.
    Gentile M, Bianchi P, Sesti F, Sopracordevole F, Biamonti A, Scirpa P, Schimberni M, Cozza G, Marziani R, Di Martino G, Catalano A, Milazzo GN, Zinna M, Caserta D, Frega A.
    Eur Rev Med Pharmacol Sci; 2014 Oct 10; 18(19):2949-52. PubMed ID: 25339491
    [Abstract] [Full Text] [Related]

  • 6. Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia.
    Winters U, Daayana S, Lear JT, Tomlinson AE, Elkord E, Stern PL, Kitchener HC.
    Clin Cancer Res; 2008 Aug 15; 14(16):5292-9. PubMed ID: 18698049
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Imiquimod for treatment of vulvar and vaginal intraepithelial neoplasia.
    Iavazzo C, Pitsouni E, Athanasiou S, Falagas ME.
    Int J Gynaecol Obstet; 2008 Apr 15; 101(1):3-10. PubMed ID: 18222451
    [Abstract] [Full Text] [Related]

  • 19. Topical imiquimod as first-line treatment for vulvar intraepithelial neoplasia.
    Voss FO, van Beurden M, Jordanova ES.
    Lancet; 2022 May 07; 399(10337):1755-1757. PubMed ID: 35483402
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.